Synthesis and Antiviral Activity of the Carbocyclic Analogue of the Highly Potent and Selective Anti-VZV Bicyclo Furano Pyrimidines

详细信息    查看全文

• 作者：Marco D. Migliore ; Nicola Zonta ; Christopher McGuigan ; Geoffrey Henson ; Graciela Andrei ; Robert Snoeck ; Jan Balzarini
• 刊名：Journal of Medicinal Chemistry
• 出版年：2007
• 出版时间：December 27, 2007
• 年：2007
• 卷：50
• 期：26
• 页码：6485 - 6492
• 全文大小：565K
• 年卷期：v.50,no.26(December 27, 2007)
• ISSN：1520-4804

文摘

Carbocyclic nucleoside analogues are catabolically stable since they are resistant to phosphorolytic cleavage by pyrimidine nucleoside phosphorylase enzymes. The carbocyclic analogue (C-BCNA) of the highly potent and selective anti-VZV bicyclic nucleoside analogue (BCNA) 6-pentylphenylfuro[2,3-d]pyrimidine-2′-deoxyribose was synthesized using carbocyclic 2′-deoxyuridine as starting material. C-BCNA was found to be chemically more stable than the furano lead, but it was shown to be significantly less antivirally active than its parent nucleoside analogue. It was noted to have a 10-fold lower inhibitory activity against the VZV-encoded thymidine kinase. This reduction of activity may be attributed to the different conformation of the sugar and base, as predicted by computational studies and supported by NMR studies. However, other factors besides affinity for VZV-TK must account for the greatly reduced antiviral potency.